张志友,刘文生,李 鹰.MiR-125b靶向A20/NF-κB信号通路促进胰腺癌细胞增殖机制的研究[J].肿瘤学杂志,2021,27(2):110-115.
MiR-125b靶向A20/NF-κB信号通路促进胰腺癌细胞增殖机制的研究
MiR-125b Promotes Proliferation of Pancreatic Cancer Cells by Targeting A20/NF-κB Signaling Pathway
投稿时间:2020-02-21  
DOI:10.11735/j.issn.1671-170X.2021.02.B005
中文关键词:  胰腺肿瘤  miRNA-125b  A20/NF-κB  增殖
英文关键词:pancreatic cancer  miRNA-125b  A20/NF-κB  proliferation
基金项目:
作者单位
张志友 南京中医药大学附属南京市中西医结合医院 
刘文生 南京中医药大学附属南京市中西医结合医院 
李 鹰 南京中医药大学附属南京市中西医结合医院 
摘要点击次数: 977
全文下载次数: 272
中文摘要:
      摘 要:[目的] 研究miR-125b在胰腺癌组织及细胞系中的表达,探讨其对胰腺癌细胞增殖的影响及作用机制。[方法] QRT-PCR检测miR-125b在60例胰腺癌患者癌组织和癌旁组织中,及3株胰腺癌细胞系和1株正常胰腺导管上皮细胞中的表达;miR-125b敲减慢病毒质粒及阴性对照空载体质粒vector感染SUIT-2细胞,经1.0μg/ml嘌呤霉素筛选稳定敲减miR-125b或vector的SUIT-2细胞,注射到BALB/c裸鼠中,观察抑制miR-125b对胰腺癌细胞体内增殖能力的影响;利用Targetscan 7.2软件及荧光素酶报告基因试验,分析miR-125b对A20基因的靶向作用;SUIT-2细胞转染miR-125b inhibit和scramble后,体外实验检测miR-125b对细胞增殖、肿瘤坏死因子α诱导的蛋白3(tumor necrosis factor α-induced protein 3,TNFAIP3,又称A20)和NF-κB信号通路关键蛋白IKKα/β、IκBα、p65的表达影响。[结果] MiR-125b在胰腺癌的组织中的表达显著高于癌旁组织 (0.99±0.21 vs 0.68±0.17,P<0.05);miR-125b在SW1990、SUIT-2、BxPC3胰腺癌细胞系中的表达显著高于在正常胰腺导管上皮细胞HPDE6-C7中的表达(4.81±0.13,8.63±0.27,5.64±0.21 vs 1.00±0.05,P均<0.05);SUIT-2miR-125b的裸鼠成瘤体积显著低于SUIT-2vector细胞(P<0.05)。TargetScan软件预测和荧光素酶报告基因实验验证A20为miR-125b的靶基因;转染miR-125b inhibit后,A20基因表达显著增加(6.98±0.18 vs 1.00±0.06,P<0.05),细胞增殖能力、NF-κB信号通路关键蛋白IKKα/β、IκBα、p65的表达显著下降(P均<0.05)。[结论] MiR-125b可通过靶向调控A20/NF-κB信号通路促进胰腺癌细胞的增殖。
英文摘要:
      Abstract:[Objective] To investigate the expression of miR-125b in pancreatic cancer tissues and cell lines,and to explore its effect on the proliferation of pancreatic cancer cells and related mechanism. [Methods] The expression of miR-125b in 60 specimens of pancreatic cancer and adjacent tissues,3 pancreatic cancer cell lines and normal pancreatic ductal epithelial cells was detected by qRT-PCR. Human pancreatic carcinoma SUIT-2 cells were transfected with miR-125b-knockdown lentiviral plasmid or with negative control vector,and screened by 1.0 μg/ml puromycin. The SUIT-2 cells with stably knocked down miR-125b or blank vector were injected into BALB/c nude mice,and the size of implanted tumors was measured in two groups. The targeting effect of miR-125b on A20 gene was analyzed by Targetscan 7.2 software and luciferase reporter gene assay. The tumor necrosis factor α-induced protein 3(TNFAIP3 or A20) and NF-κB signaling pathway related proteins IKKα/β,IκBα,p65 were measured with Western blotting. [Results] The expression of miR-125b in pancreatic cancer tissue was significantly higher than that in adjacent tissues(0.99±0.21 vs 0.68±0.17,P<0.05).The miR-125b expression in SW1990,SUIT-2,BxPC3 pancreatic cancer cell lines was significantly higher than that in normal pancreatic ductal epithelial cells HPDE6-C7(4.81±0.13,8.63±0.27,5.64±0.21 vs 1.00±0.05,all P<0.05). The tumor size in SUIT-2miR-125b nude mice was significantly lower than that in SUIT-2vector nude mice(P<0.05). TargetScan software and luciferase reporter gene assay indicated that the target gene of miR-125b was A20. After transfection with miR-125b inhibit,A20 gene expression was significantly increased,cell proliferation ability decreased,the expression of NF-κB signaling pathway key proteins IKKα/β,IκBα,p65 decreased significantly(P<0.05). [Conclusion] MiR-125b can promote the proliferation of pancreatic cancer cells by targeting A20/NF-κB signaling pathway.
在线阅读   查看全文  查看/发表评论  下载PDF阅读器